NCCAM
This article was originally published in The Tan Sheet
Executive Summary
NIH center's program advisory panel holding its initial meeting July 8-9 at the Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, Md. The agenda includes comments from NCCAM Acting Director William Harlan, MD, and other NIH staffers, as well as scientific presentations on alternative cancer treatments. The meeting will be open to the public from 8:30 a.m. to 12:15 p.m. on July 8 and from 8:30 a.m. to 1:30 p.m. July 9; people wishing to make public comments should contact Richard Nahin at (301)-594-2013. The advisory panel originally met Nov. 16 but subsequently had to revise its charter ("The Tan Sheet" March 8, p. 7)
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning